, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Neutral REGN

Regeneron Pharmaceuticals, Inc. (REGN) rated Neutral with price target $490 by ROTH Capital

Posted on: Thursday,  May 7, 2015  1:25 PM ET by Roth Capital

Roth Capital rated Neutral Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 05/07/2015. Previously Roth Capital rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on
11/19/2014., when the stock price was $418.45. Since then, Regeneron Pharmaceuticals, Inc. has gained 1.57% as of 02/19/2015's recent price of $425.00.
If you would have followed the previous Roth Capital's recommendation on REGN, you would have gained 1.56% of your investment in 92 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/7/2015 1:25 PM Hold
469.14 490.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  54.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/19/2015 5:25 PM Hold
425.00 461.00
11/19/2014 11:25 AM Buy
418.45 461.00
1/7/2010 9:25 AM Buy
24.96 35.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy